We are live on
!
Find out more
RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
161 hedge funds and large institutions have $1.56B invested in Revance Therapeutics, Inc. in 2021 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 55 increasing their positions, 44 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
92% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 13
25% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 44
8% more funds holding
Funds holding: 149 → 161 (+12)
2% more capital invested
Capital invested by funds: $1.53B → $1.56B (+$33.1M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
41% less call options, than puts
Call options by funds: $6.68M | Put options by funds: $11.2M
Holders
161
Holders Change
+12
Holders Change %
+8.05%
% of All Funds
2.8%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
25
Increased
55
Reduced
44
Closed
13
Calls
$6.68M
Puts
$11.2M
Net Calls
-$4.55M
Net Calls Change
-$5.08M
Top Buyers
| 1 |
JP Morgan Chase
New York
|
+$17.6M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$11.4M |
| 3 |
PC
Pier Capital
Stamford,
Connecticut
|
+$4.91M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$4.32M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$4.09M |
